BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Q, Zhu X, Song W, Peng X, Zhao R. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer. J Cancer Res Clin Oncol 2020;146:2731-41. [PMID: 32892231 DOI: 10.1007/s00432-020-03379-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Rotondo JC, Mazziotta C, Lanzillotti C, Stefani C, Badiale G, Campione G, Martini F, Tognon M. The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications. Cancers (Basel) 2022;14:1116. [PMID: 35267424 DOI: 10.3390/cancers14051116] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
2 Wei Z, Zeng X, Lei Y, He H, Jamal M, Zhang C, Tan H, Xie S, Zhang Q. TTYH3, a potential prognosis biomarker associated with immune infiltration and immunotherapy response in lung cancer. Int Immunopharmacol 2022;110:108999. [PMID: 35858518 DOI: 10.1016/j.intimp.2022.108999] [Reference Citation Analysis]
3 Ai X, Dong X, Guo Y, Yang P, Hou Y, Bai J, Zhang S, Wang X. Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment. Purinergic Signal 2021;17:229-40. [PMID: 33751327 DOI: 10.1007/s11302-021-09774-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Di Virgilio F, Vultaggio-Poma V, Sarti AC. P2X receptors in cancer growth and progression. Biochem Pharmacol 2021;187:114350. [PMID: 33253643 DOI: 10.1016/j.bcp.2020.114350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tang Y, Qiao C, Li Q, Zhu X, Zhao R, Peng X. Research Progress in the Relationship Between P2X7R and Cervical Cancer. Reprod Sci 2022. [PMID: 35799022 DOI: 10.1007/s43032-022-01022-w] [Reference Citation Analysis]
6 Qiao C, Tang Y, Li Q, Zhu X, Peng X, Zhao R. ATP-gated P2X7 receptor as a potential target for prostate cancer. Hum Cell 2022. [PMID: 35657562 DOI: 10.1007/s13577-022-00729-x] [Reference Citation Analysis]
7 Han Y, Bai C, He XM, Ren QL. P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells. Purinergic Signal 2022. [PMID: 35235139 DOI: 10.1007/s11302-022-09854-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]